AAO 2019 Retina Street Team: Key takeaways

October 13, 2019

Judy E. Kim, MD; David M. Brown, MD; and Charlie C. Wykoff, MD,PhD, share their take on key highlights - what’s in the pharmaceutical pipelines, upcoming and ongoing clinical trials, and the latest update in gene therapy - from the 2019 meeting of the American Academy of Ophthalmology.

Judy E. Kim, MD; David M. Brown, MD; and Charlie C. Wykoff, MD,PhD, share their take on key highlights - what’s in the pharmaceutical pipelines, upcoming and ongoing clinical trials, and the latest update in gene therapy - from the 2019 meeting of the American Academy of Ophthalmology.

Judy E. Kim, MD; David M. Brown, MD; and Charles C. Wykoff, MD,PhD, share their take on key highlights - what’s in the pharmaceutical pipelines, upcoming and ongoing clinical trials, and the latest update in gene therapy - from the 2019 meeting of the American Academy of Ophthalmology.

Read and watch more highlights from the AAO 2019 Retina Street Team.